Evidence map›Paper›PMID 28344780›Full record

ArticleCilia2017

Abnormal glycosylation in Joubert syndrome type 10.

Megan S Kane, Mariska Davids, Michelle R Bond, Christopher J Adams, Megan E Grout, Ian G Phelps, Diana R O'Day, Jennifer C Dempsey, Xeuli Li, Gretchen Golas and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Cilia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. OFD1: One gene, several disorders.American journal of medical genetics. Part C, Seminars in medical genetics · 2022
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 10 institutions in 2 countries.

Megan S Kane *NIH Undiagnosed Disease Program, Common Fund, Office of the Director, and National Human Genome Research Institute, National Institutes of Health, Bethesda, MD USA.
Mariska Davids *NIH Undiagnosed Disease Program, Common Fund, Office of the Director, and National Human Genome Research Institute, National Institutes of Health, Bethesda, MD USA.
Michelle R BondNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD USA.
Christopher J AdamsNIH Undiagnosed Disease Program, Common Fund, Office of the Director, and National Human Genome Research Institute, National Institutes of Health, Bethesda, MD USA.
Megan E GroutDepartment of Pediatrics, University of Washington, Seattle, WA USA.
Ian G PhelpsDepartment of Pediatrics, University of Washington, Seattle, WA USA.
Diana R O'DayDepartment of Pediatrics, University of Washington, Seattle, WA USA.
Jennifer C DempseyDepartment of Pediatrics, University of Washington, Seattle, WA USA.
Xeuli LiThe Michael J Palmieri Metabolic Laboratory, Children's Hospital of Philadelphia, Philadelphia, PA USA.
Gretchen GolasNIH Undiagnosed Disease Program, Common Fund, Office of the Director, and National Human Genome Research Institute, National Institutes of Health, Bethesda, MD USA.
Gilbert VezinaChildren's National Medical Center, Washington, DC USA.
Meral Gunay-AygunMedical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD USA.
John A HanoverNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD USA.
Dan DohertyDepartment of Pediatrics, University of Washington, Seattle, WA USA.
Miao HeThe Michael J Palmieri Metabolic Laboratory, Children's Hospital of Philadelphia, Philadelphia, PA USA.
May Christine V MalicdanNIH Undiagnosed Disease Program, Common Fund, Office of the Director, and National Human Genome Research Institute, National Institutes of Health, Bethesda, MD USA.
William A GahlNIH Undiagnosed Disease Program, Common Fund, Office of the Director, and National Human Genome Research Institute, National Institutes of Health, Bethesda, MD USA.
Cornelius F BoerkoelNIH Undiagnosed Disease Program, Common Fund, Office of the Director, and National Human Genome Research Institute, National Institutes of Health, Bethesda, MD USA.
University of Washington · USChildren's Hospital of Philadelphia · USNational Human Genome Research Institute · USNational Institutes of Health · USOffice of the Director · USChildren's National · USInova Health System · USJohns Hopkins University · USNational Institute of Diabetes and Digestive and Kidney Diseases · USUniversity of British Columbia · CA

Funding

NHGRI/DIR Clinical Support ServicesZIDHG200352 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI SOLOMON, BENJAMIN · 2009 to 2025
$182.8M
Human Biochemical GeneticsZIAHG000215 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI GAHL, WILLIAM · 2009 to 2025
$72.6M
Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of DiseaseZIADK060101 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HANOVER, JOHN A. · 2009 to 2025
$25.7M
Enzymes of O-GlcNAc cycling linked to type-2 diabetes and neurodegenerationZIADK060103 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HANOVER, JOHN A. · 2009 to 2025
$20.8M
Intellectual and Developmental Disabilities Research CenterU54HD083091 · NICHD · UNIVERSITY OF WASHINGTON · PI GARDEN, GWENN A · 2014 to 2019
$7.9M
Joubert syndrome and related disorders of hindbrain developmentR01NS064077 · NINDS · UNIVERSITY OF WASHINGTON · PI DOHERTY, DANIEL · 2010 to 2014
$1.8M
NICHD NIH HHS U54 HD083091NINDS NIH HHS R01 NS064077
6 · The paper itself

Abstract

backgroundThe discovery of disease pathogenesis requires systematic agnostic screening of multiple homeostatic processes that may become deregulated. We illustrate this principle in the evaluation and diagnosis of a 5-year-old boy with Joubert syndrome type 10 (JBTS10). He carried the OFD1 mutation p.Gln886Lysfs*2 (NM_003611.2: c.2656del) and manifested features of Joubert syndrome.

methodsWe integrated exome sequencing, MALDI-TOF mass spectrometry analyses of plasma and cultured dermal fibroblasts glycomes, and full clinical evaluation of the proband. Analyses of cilia formation and lectin staining were performed by immunofluorescence. Measurement of cellular nucleotide sugar levels was performed with high-performance anion-exchange chromatography with pulsed amperometric detection. Statistical analyses utilized the Student's and Fisher's exact

resultsGlycome analyses of plasma and cultured dermal fibroblasts identified abnormal

conclusionsThe rescue of ciliogenesis and glycosylation upon reintroduction of WT

Indexed as

CiliopathyCMP-sialic acidGlycosylationJoubert syndromeMolar tooth sign

Identifiers

PMID28344780
PMCPMC5364566
OpenAlexW2603349122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.